Blom et al . ([1][1]) challenge several studies ([2–6][2]) that showed that osteopontin (OPN) plays a key role in the progression of autoimmune disease in models of multiple sclerosis (MS) and rheumatoid arthritis. According to Blom et al. , the results of the study by Chabas et al . ([2][2]) and
No takes yet. Share an insight, caveat, or question.
Steinman et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: